Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Malapetsa

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Cancer Research|March 15, 1994
Altered cytotoxicity of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in human glioma cell lines SK-MG-1 and SKI-1 correlates with differential transport kineticsA J Noë, A Malapetsa, L C Panasci
Molecular Pharmacology|July 1, 1993
Transport of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in the human glioma cell line SK-MG-1 is mediated by an epinephrine-sensitive carrier systemA J Noë, A Malapetsa, L C Panasci
Cancer Research|September 1, 1995
Re: M. D. Dabholkar et al., Malignant and nonmalignant brain tissues differ in their messenger RNA expression patterns for ERCC1 and ERCC2. Cancer Res., 55: 1261-1266, 1995L Panasci, A McQuillan, A Malapetsa, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Lack of evidence for a high-affinity sarcosinamide carrier or a catecholamine carrier in Calu-1 lung-cancer cells, HT-29 colon-cancer cells, and DHF fibroblastsA Malapetsa, J L Bramson, A J Noë, et al.
Biochemical Pharmacology|June 28, 1996
Characterization of the catecholamine extraneuronal uptake2 carrier in human glioma cell lines SK-MG-1 and SKI-1 in relation to (2-chloroethyl)-3-sarcosinamide-1-nitrosourea (SarCNU) selective cytotoxicityA J Noë, D Marcantonio, J Barton, et al.
Analytical Biochemistry|January 1, 1997
Quantitation of ERCC-2 gene expression in human tumor cell lines by reverse transcription-polymerase chain reaction in comparison to northern blot analysisZ P Chen, A Malapetsa, G Mohr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2001
Chlorambucil drug resistance in chronic lymphocytic leukemia: the emerging role of DNA repairL Panasci, J P Paiement, G Christodoulopoulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Chlorambucil induction of HsRad51 in B-cell chronic lymphocytic leukemiaG Christodoulopoulos, A Malapetsa, H Schipper, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|April 20, 2001
Comparative analysis of human, bovine, and murine Oct-4 upstream promoter sequencesV Nordhoff, K Hübner, A Bauer, et al.
Cancer Research|June 1, 1996
Correlation of chloroethylnitrosourea resistance with ERCC-2 expression in human tumor cell lines as determined by quantitative competitive polymerase chain reactionZ P Chen, A Malapetsa, D Marcantonio, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cancer Research|March 15, 1994
Altered cytotoxicity of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in human glioma cell lines SK-MG-1 and SKI-1 correlates with differential transport kineticsA J Noë, A Malapetsa, L C Panasci
Molecular Pharmacology|July 1, 1993
Transport of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in the human glioma cell line SK-MG-1 is mediated by an epinephrine-sensitive carrier systemA J Noë, A Malapetsa, L C Panasci
Cancer Research|September 1, 1995
Re: M. D. Dabholkar et al., Malignant and nonmalignant brain tissues differ in their messenger RNA expression patterns for ERCC1 and ERCC2. Cancer Res., 55: 1261-1266, 1995L Panasci, A McQuillan, A Malapetsa, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Lack of evidence for a high-affinity sarcosinamide carrier or a catecholamine carrier in Calu-1 lung-cancer cells, HT-29 colon-cancer cells, and DHF fibroblastsA Malapetsa, J L Bramson, A J Noë, et al.
Biochemical Pharmacology|June 28, 1996
Characterization of the catecholamine extraneuronal uptake2 carrier in human glioma cell lines SK-MG-1 and SKI-1 in relation to (2-chloroethyl)-3-sarcosinamide-1-nitrosourea (SarCNU) selective cytotoxicityA J Noë, D Marcantonio, J Barton, et al.
Analytical Biochemistry|January 1, 1997
Quantitation of ERCC-2 gene expression in human tumor cell lines by reverse transcription-polymerase chain reaction in comparison to northern blot analysisZ P Chen, A Malapetsa, G Mohr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2001
Chlorambucil drug resistance in chronic lymphocytic leukemia: the emerging role of DNA repairL Panasci, J P Paiement, G Christodoulopoulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Chlorambucil induction of HsRad51 in B-cell chronic lymphocytic leukemiaG Christodoulopoulos, A Malapetsa, H Schipper, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|April 20, 2001
Comparative analysis of human, bovine, and murine Oct-4 upstream promoter sequencesV Nordhoff, K Hübner, A Bauer, et al.
Cancer Research|June 1, 1996
Correlation of chloroethylnitrosourea resistance with ERCC-2 expression in human tumor cell lines as determined by quantitative competitive polymerase chain reactionZ P Chen, A Malapetsa, D Marcantonio, et al.
Pageof 2